Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2021-01-22 History
Report ID 129882
Drug Identification Number 02439379
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name Ropivacaine Hydrochloride Injection, USP, 2 mg/mL freeflex® Bag 100 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL INFILTRATION INFILTRATION EPIDURAL
Packaging size 100 mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-12-21
Actual start date
Estimated end date 2021-01-04
Actual end date 2021-01-21
Shortage status Resolved
Updated date 2021-01-22
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 100 mL will be available at Ontario distribution centers on Thursday, January 21, 2021 and at all other distribution centers by Friday, January 22, 2021. Please note the product will be placed on allocation. Contract customers will be allocated 100% of their historical average monthly volumes, effective Thursday, January 21, 2021.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-01-22 English Compare
v9 2021-01-21 French Compare
v8 2021-01-21 English Compare
v7 2021-01-21 English Compare
v6 2021-01-21 French Compare
v5 2021-01-21 English Compare
v4 2021-01-21 English Compare
v3 2020-12-22 English Compare
v2 2020-12-09 French Compare
v1 2020-12-09 English Compare

Showing 1 to 10 of 10